Kingdon Capital Management, L.L.C. Iveric Bio, Inc. Transaction History

Kingdon Capital Management, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$26.24 - $39.63 $1.91 Million - $2.89 Million	-72,950 Reduced 6.93%	980,050 $38.6 Million
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $3.73 Million - $4.91 Million	200,000 Added 23.45%	1,053,000 $25.6 Million
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $14.7 Million - $20.4 Million	853,000 New	853,000 $18.3 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.